LITTLE KNOWN FACTS ABOUT DEPO 10.

Sizeable changes (maximize or minimize) inside the plasma levels of the progestin are already noted in some cases of co-administration with non-nucleoside reverse transcriptase inhibitors.Regime DXA for BMD monitoring is not advisable in adolescents and younger women making use of DMPA simply because DXA has not been validated in these populations.